Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Liver Cirrhosis

  Free Subscription


04.10.2021

2 Dig Dis Sci
2 Gastroenterology
1 Hepatology
2 J Hepatol
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Dig Dis Sci

  1. PATEL YA, Yao J, Proeschold-Bell RJ, Niedzwiecki D, et al
    Reduced Alcohol Use Is Sustained in Patients Provided Alcohol-Related Counseling During Direct-Acting Antiviral Therapy for Hepatitis C.
    Dig Dis Sci. 2020 Sep 23. pii: 10.1007/s10620-020-06616.
    PubMed         Abstract available

  2. RITACCIO G, Stoleru G, Abutaleb A, Cross RK, et al
    Nonalcoholic Fatty Liver Disease Is Common in IBD Patients However Progression to Hepatic Fibrosis by Noninvasive Markers Is Rare.
    Dig Dis Sci. 2020 Sep 7. pii: 10.1007/s10620-020-06588.
    PubMed         Abstract available


    Gastroenterology

  3. INTAGLIATA NM, Davitkov P, Allen AM, Falck-Ytter YT, et al
    AGA Technical Review on Coagulation in Cirrhosis.
    Gastroenterology. 2021 Sep 24. pii: S0016-5085(21)03477.
    PubMed        

  4. O'SHEA RS, Davitkov P, Ko CW, Rajasekhar A, et al
    AGA Clinical Practice Guideline on the Management of Coagulation Disorders in Patients With Cirrhosis.
    Gastroenterology. 2021 Sep 24. pii: S0016-5085(21)03382.
    PubMed        


    Hepatology

  5. GARCIA-TSAO G
    Can we rely on changes in HVPG in patients with cirrhosis?
    Hepatology. 2021 Sep 27. doi: 10.1002/hep.32159.
    PubMed         Abstract available


    J Hepatol

  6. D'AMBROSIO R, Degasperi E, Anolli MP, Fanetti I, et al
    Incidence of liver and non-liver-related outcomes in patients with HCV-cirrhosis after SVR.
    J Hepatol. 2021 Sep 27. pii: S0168-8278(21)02043.
    PubMed         Abstract available

  7. PATEL V, Lee S, McPhail M, Da Silva K, et al
    Rifaximin reduces gut-derived inflammation and mucin degradation in cirrhosis and encephalopathy: RIFSYS randomised controlled trial.
    J Hepatol. 2021 Sep 24. pii: S0168-8278(21)02040.
    PubMed         Abstract available


    PLoS One

  8. VIEIRA BARBOSA J, Sahli R, Aubert V, Chaouch A, et al
    Demographics and outcomes of hepatitis B and D: A 10-year retrospective analysis in a Swiss tertiary referral center.
    PLoS One. 2021;16:e0250347.
    PubMed         Abstract available

  9. SUENAGA R, Suka M, Hirao T, Hidaka I, et al
    Cost-effectiveness of a "treat-all" strategy using Direct-Acting Antivirals (DAAs) for Japanese patients with chronic hepatitis C genotype 1 at different fibrosis stages.
    PLoS One. 2021;16:e0248748.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Cirrhosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: